No Data
No Data
Cofoe Medical Technology to Invest In 45 Million Yuan Venture Capital Fund for Healthcare Industry
Kangfu Medical (301087.SZ) participates in the Hunan Dingxin Kexin Venture Capital Fund, primarily investing in the Medical health and related Industries.
Kefuch Medical (301087.SZ) announced that the company has partnered with Hunan Dingxintaihe Private Equity Management Co., Ltd. (abbreviated...)
Sinolink: The end of year centralized purchasing expectations are gradually being cleared, and the pharmaceutical sector行情 is expected to gradually start.
The pharmaceutical Sector is currently in a process of a triple reversal in performance, policies, and funding, with full confidence in the recovery of revenue profit growth and market resurgence of listed companies in the Sector by 2025.
Cofoe Medical TechnologyLtd (SZSE:301087) Seems To Use Debt Quite Sensibly
Sinolink Securities: The favorable wind of medical policies arrives first, followed by innovation going abroad and performance reversal.
In 2025, Sinolink believes that the core investment opportunities in the pharmaceutical Sector will revolve around three main logics: 1) innovation going abroad; 2) demand recovery; 3) reversal of policy expectations.
Kefo Medical (301087.SZ) invested 9 million yuan to establish a life and health investment fund, Xiangjiang Shannuo.
KeFu Medical (301087.SZ) announced that the company has entered into an agreement with Shenzhen Qianhai Shangshan Jinshi Private Equity Fund Management Co., Ltd...
